asthma_1.jpg

Asthma is an inflammatory disease of the lungs. It makes breathing difficult and brings on attacks of coughing, wheezing, tightness in the chest and shortness of breath. 

 

​The exact cause of asthma is not known; it is suspected to be due to genetic and/or environmental factors. Most commonly observed symptoms include shortness of breath, wheezing, coughing and tightness in the chest. Asthma can be controlled with medications.

A multicenter, randomized, parallel-group, placebo-controlled, 4-week clinical endpoint bioequivalence study comparing fluticasone propionate/salmeterol 100/50 μg inhalation powder (Cipla Ltd., India) with Advair® Diskus 100/50 μg (GlaxoSmithKline, USA) in Asthma patients.

 

PROTOCOL:​  U-FS-MU-AS3120.

SPONSOR:​  Cipla Ltd., India

 

STATUS:​  Open, enrolling now...!

TRIAL PERIOD:​  5 WEEKS.

ENROLLED:​   65 SUBJECTS.

RANDOMIZED:​  37 SUBJECTS.

Clinical Trials

  • Facebook - Black Circle
  • Twitter - Black Circle
  • Instagram - Black Circle
  • TripAdvisor - Black Circle

Pharmax Research of South Florida, Inc.

© 2018 All rights reserved

research@pharmaxSF.com

by Rene Perez, CCRN

Researching... for a better future!